Targeting rare and non-canonical driver variants in NSCLC: an uncharted clinical field
Objectives - Implementation of tyrosine kinase inhibitors (TKI) and other targeted therapies was a main advance in thoracic oncology with survival gains ranging from several months to years for non-small-cell lung cancer (NSCLC) patients. High-throughput comprehensive molecular profiling is of key i...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 February 2021
|
| In: |
Lung cancer
Year: 2021, Jahrgang: 154, Pages: 131-141 |
| ISSN: | 1872-8332 |
| DOI: | 10.1016/j.lungcan.2021.02.022 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.lungcan.2021.02.022 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0169500221000829 
|
| Verfasserangaben: | Anna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, Michael Allgäuer, Olaf Neumann, Jan Budczies, Eugen Rempel, Peter Horak, Julia Glade, Hannah Goldschmid, Huriye Seker-Cin, Regine Brandt, Mark Kriegsmann, Jonas Leichsenring, Hauke Winter, Martin Faehling, Jürgen R. Fischer, Claus Peter Heußel, Felix Herth, Tilman Brummer, Stefan Fröhling, Peter Schirmacher, Michael Thomas, Volker Endris, Roland Penzel, Daniel Kazdal, Tilmann Bochtler, Albrecht Stenzinger |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1759026352 | ||
| 003 | DE-627 | ||
| 005 | 20250820120023.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210527s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lungcan.2021.02.022 |2 doi | |
| 035 | |a (DE-627)1759026352 | ||
| 035 | |a (DE-599)KXP1759026352 | ||
| 035 | |a (OCoLC)1341414562 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Volckmar, Anna-Lena |d 1984- |e VerfasserIn |0 (DE-588)173874916 |0 (DE-627)698776666 |0 (DE-576)134713478 |4 aut | |
| 245 | 1 | 0 | |a Targeting rare and non-canonical driver variants in NSCLC |b an uncharted clinical field |c Anna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, Michael Allgäuer, Olaf Neumann, Jan Budczies, Eugen Rempel, Peter Horak, Julia Glade, Hannah Goldschmid, Huriye Seker-Cin, Regine Brandt, Mark Kriegsmann, Jonas Leichsenring, Hauke Winter, Martin Faehling, Jürgen R. Fischer, Claus Peter Heußel, Felix Herth, Tilman Brummer, Stefan Fröhling, Peter Schirmacher, Michael Thomas, Volker Endris, Roland Penzel, Daniel Kazdal, Tilmann Bochtler, Albrecht Stenzinger |
| 264 | 1 | |c 19 February 2021 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.05.2021 | ||
| 520 | |a Objectives - Implementation of tyrosine kinase inhibitors (TKI) and other targeted therapies was a main advance in thoracic oncology with survival gains ranging from several months to years for non-small-cell lung cancer (NSCLC) patients. High-throughput comprehensive molecular profiling is of key importance to identify patients that can potentially benefit from these novel treatments. - Material and Methods - Next-generation sequencing (NGS) was performed on 4500 consecutive formalin-fixed, paraffin-embedded specimens of advanced NSCLC (n=4172 patients) after automated extraction of DNA and RNA for parallel detection of mutations and gene fusions, respectively. - Results and Conclusion - Besides the 24.9 % (n=1040) of cases eligible for approved targeted therapies based on the presence of canonical alterations in EGFR exons 18-21, BRAF, ROS1, ALK, NTRK, and RET, an additional n=1260 patients (30.2 %) displayed rare or non-canonical mutations in EGFR (n=748), BRAF (n=135), ERBB2 (n=30), KIT (n=32), PIK3CA (n=221), and CTNNB1 (n=94), for which targeted therapies could also be potentially effective. A systematic literature search in conjunction with in silico evaluation identified n=232 (5.5 %) patients, for which a trial of targeted treatment would be warranted according to available evidence (NCT level 1, i.e. published data showing efficacy in the same tumor entity). In conclusion, a sizeable fraction of NSCLC patients harbors rare or non-canonical alterations that may be associated with clinical benefit from currently available targeted drugs. Systematic identification and individualized management of these cases can expand applicability of precision oncology in NSCLC and extend clinical gain from established molecular targets. These results can also inform clinical trials. | ||
| 650 | 4 | |a Atypical variants | |
| 650 | 4 | |a Drug target | |
| 650 | 4 | |a Gene fusion | |
| 650 | 4 | |a Lung adenocarcinoma | |
| 650 | 4 | |a Next-generation sequencing | |
| 700 | 1 | |a Christopoulos, Petros |d 1977- |e VerfasserIn |0 (DE-588)138659702 |0 (DE-627)604886756 |0 (DE-576)308488067 |4 aut | |
| 700 | 1 | |a Kirchner, Martina |d 1973- |e VerfasserIn |0 (DE-588)1017178976 |0 (DE-627)676266363 |0 (DE-576)353239747 |4 aut | |
| 700 | 1 | |a Allgäuer, Michael |e VerfasserIn |0 (DE-588)1178366790 |0 (DE-627)1049312597 |0 (DE-576)517751453 |4 aut | |
| 700 | 1 | |a Neumann, Olaf |e VerfasserIn |0 (DE-588)1033375632 |0 (DE-627)741119498 |0 (DE-576)380962381 |4 aut | |
| 700 | 1 | |a Budczies, Jan |d 1970- |e VerfasserIn |0 (DE-588)124086403 |0 (DE-627)706532724 |0 (DE-576)186167679 |4 aut | |
| 700 | 1 | |a Rempel, Eugen |d 1979- |e VerfasserIn |0 (DE-588)1116610396 |0 (DE-627)870570269 |0 (DE-576)478523572 |4 aut | |
| 700 | 1 | |a Horak, Peter |e VerfasserIn |0 (DE-588)1156426111 |0 (DE-627)1019252839 |0 (DE-576)502179961 |4 aut | |
| 700 | 1 | |a Glade, Julia |e VerfasserIn |0 (DE-588)122575433X |0 (DE-627)1745638369 |4 aut | |
| 700 | 1 | |a Goldschmid, Hannah |e VerfasserIn |0 (DE-588)1211651568 |0 (DE-627)1700253530 |4 aut | |
| 700 | 1 | |a Şeker-Cin, Huriye |e VerfasserIn |0 (DE-588)1083854712 |0 (DE-627)848056949 |0 (DE-576)455756902 |4 aut | |
| 700 | 1 | |a Brandt, Regine |e VerfasserIn |0 (DE-588)106314762X |0 (DE-627)81064696X |0 (DE-576)420525084 |4 aut | |
| 700 | 1 | |a Kriegsmann, Mark |d 1987- |e VerfasserIn |0 (DE-588)103740324X |0 (DE-627)755668782 |0 (DE-576)39141870X |4 aut | |
| 700 | 1 | |a Leichsenring, Jonas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Winter, Hauke |e VerfasserIn |0 (DE-588)1162076038 |0 (DE-627)1025509773 |0 (DE-576)176791531 |4 aut | |
| 700 | 1 | |a Faehling, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fischer, Jürgen |d 1953- |e VerfasserIn |0 (DE-588)133724484 |0 (DE-627)691747725 |0 (DE-576)300052510 |4 aut | |
| 700 | 1 | |a Heußel, Claus Peter |e VerfasserIn |0 (DE-588)1048631389 |0 (DE-627)780769422 |0 (DE-576)40288146X |4 aut | |
| 700 | 1 | |a Herth, Felix |e VerfasserIn |0 (DE-588)1016095236 |0 (DE-627)705477568 |0 (DE-576)351509925 |4 aut | |
| 700 | 1 | |a Brummer, Tilman |d 1970- |e VerfasserIn |0 (DE-588)1100289917 |0 (DE-627)859263010 |0 (DE-576)469586729 |4 aut | |
| 700 | 1 | |a Fröhling, Stefan |d 1969- |e VerfasserIn |0 (DE-588)120890046 |0 (DE-627)080950302 |0 (DE-576)188733930 |4 aut | |
| 700 | 1 | |a Schirmacher, Peter |d 1961- |e VerfasserIn |0 (DE-588)1020440112 |0 (DE-627)691221197 |0 (DE-576)360427448 |4 aut | |
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 700 | 1 | |a Endris, Volker |e VerfasserIn |0 (DE-588)1063753686 |0 (DE-627)812590961 |0 (DE-576)422898198 |4 aut | |
| 700 | 1 | |a Penzel, Roland |e VerfasserIn |0 (DE-588)102044021X |0 (DE-627)691221316 |0 (DE-576)360421083 |4 aut | |
| 700 | 1 | |a Kazdal, Daniel |d 1983- |e VerfasserIn |0 (DE-588)114929650X |0 (DE-627)1009614088 |0 (DE-576)496635867 |4 aut | |
| 700 | 1 | |a Bochtler, Tilmann |d 1975- |e VerfasserIn |0 (DE-588)128398957 |0 (DE-627)372639925 |0 (DE-576)187323909 |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lung cancer |d Amsterdam [u.a.] : Elsevier, 1985 |g 154(2021) vom: Apr., Seite 131-141 |h Online-Ressource |w (DE-627)320649733 |w (DE-600)2025812-4 |w (DE-576)264627539 |x 1872-8332 |7 nnas |a Targeting rare and non-canonical driver variants in NSCLC an uncharted clinical field |
| 773 | 1 | 8 | |g volume:154 |g year:2021 |g month:04 |g pages:131-141 |g extent:11 |a Targeting rare and non-canonical driver variants in NSCLC an uncharted clinical field |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.lungcan.2021.02.022 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0169500221000829 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210527 | ||
| 992 | |a 20210527 | ||
| 993 | |a Article | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 994 | |a 2021 | ||
| 998 | |g 133724484 |a Fischer, Jürgen |m 133724484:Fischer, Jürgen |d 50000 |e 50000PF133724484 |k 0/50000/ |p 17 | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 28 |y j | ||
| 998 | |g 128398957 |a Bochtler, Tilmann |m 128398957:Bochtler, Tilmann |d 910000 |d 910100 |d 50000 |e 910000PB128398957 |e 910100PB128398957 |e 50000PB128398957 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 27 | ||
| 998 | |g 114929650X |a Kazdal, Daniel |m 114929650X:Kazdal, Daniel |d 910000 |d 912000 |e 910000PK114929650X |e 912000PK114929650X |k 0/910000/ |k 1/910000/912000/ |p 26 | ||
| 998 | |g 102044021X |a Penzel, Roland |m 102044021X:Penzel, Roland |d 910000 |d 912000 |e 910000PP102044021X |e 912000PP102044021X |k 0/910000/ |k 1/910000/912000/ |p 25 | ||
| 998 | |g 1063753686 |a Endris, Volker |m 1063753686:Endris, Volker |d 910000 |d 912000 |e 910000PE1063753686 |e 912000PE1063753686 |k 0/910000/ |k 1/910000/912000/ |p 24 | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PT1054438781 |e 950000PT1054438781 |e 950900PT1054438781 |e 50000PT1054438781 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 23 | ||
| 998 | |g 1020440112 |a Schirmacher, Peter |m 1020440112:Schirmacher, Peter |d 910000 |d 912000 |e 910000PS1020440112 |e 912000PS1020440112 |k 0/910000/ |k 1/910000/912000/ |p 22 | ||
| 998 | |g 120890046 |a Fröhling, Stefan |m 120890046:Fröhling, Stefan |d 50000 |e 50000PF120890046 |k 0/50000/ |p 21 | ||
| 998 | |g 1016095236 |a Herth, Felix |m 1016095236:Herth, Felix |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PH1016095236 |e 950000PH1016095236 |e 950900PH1016095236 |e 50000PH1016095236 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 19 | ||
| 998 | |g 1048631389 |a Heußel, Claus Peter |m 1048631389:Heußel, Claus Peter |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PH1048631389 |e 950000PH1048631389 |e 950900PH1048631389 |e 50000PH1048631389 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 18 | ||
| 998 | |g 1162076038 |a Winter, Hauke |m 1162076038:Winter, Hauke |d 50000 |e 50000PW1162076038 |k 0/50000/ |p 15 | ||
| 998 | |g 103740324X |a Kriegsmann, Mark |m 103740324X:Kriegsmann, Mark |d 910000 |d 912000 |d 50000 |e 910000PK103740324X |e 912000PK103740324X |e 50000PK103740324X |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 13 | ||
| 998 | |g 106314762X |a Brandt, Regine |m 106314762X:Brandt, Regine |d 910000 |d 912000 |e 910000PB106314762X |e 912000PB106314762X |k 0/910000/ |k 1/910000/912000/ |p 12 | ||
| 998 | |g 1083854712 |a Şeker-Cin, Huriye |m 1083854712:Şeker-Cin, Huriye |p 11 | ||
| 998 | |g 1211651568 |a Goldschmid, Hannah |m 1211651568:Goldschmid, Hannah |d 910000 |d 912000 |e 910000PG1211651568 |e 912000PG1211651568 |k 0/910000/ |k 1/910000/912000/ |p 10 | ||
| 998 | |g 122575433X |a Glade, Julia |m 122575433X:Glade, Julia |d 910000 |d 912000 |e 910000PG122575433X |e 912000PG122575433X |k 0/910000/ |k 1/910000/912000/ |p 9 | ||
| 998 | |g 1156426111 |a Horak, Peter |m 1156426111:Horak, Peter |d 50000 |e 50000PH1156426111 |k 0/50000/ |p 8 | ||
| 998 | |g 1116610396 |a Rempel, Eugen |m 1116610396:Rempel, Eugen |d 50000 |e 50000PR1116610396 |k 0/50000/ |p 7 | ||
| 998 | |g 124086403 |a Budczies, Jan |m 124086403:Budczies, Jan |d 910000 |d 912000 |d 50000 |e 910000PB124086403 |e 912000PB124086403 |e 50000PB124086403 |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 6 | ||
| 998 | |g 1033375632 |a Neumann, Olaf |m 1033375632:Neumann, Olaf |d 910000 |d 912000 |e 910000PN1033375632 |e 912000PN1033375632 |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 1178366790 |a Allgäuer, Michael |m 1178366790:Allgäuer, Michael |d 910000 |d 912000 |e 910000PA1178366790 |e 912000PA1178366790 |k 0/910000/ |k 1/910000/912000/ |p 4 | ||
| 998 | |g 1017178976 |a Kirchner, Martina |m 1017178976:Kirchner, Martina |d 50000 |e 50000PK1017178976 |k 0/50000/ |p 3 | ||
| 998 | |g 138659702 |a Christopoulos, Petros |m 138659702:Christopoulos, Petros |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PC138659702 |e 950000PC138659702 |e 950900PC138659702 |e 50000PC138659702 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 2 | ||
| 998 | |g 173874916 |a Volckmar, Anna-Lena |m 173874916:Volckmar, Anna-Lena |d 910000 |d 912000 |e 910000PV173874916 |e 912000PV173874916 |k 0/910000/ |k 1/910000/912000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1759026352 |e 3931726967 | ||
| 999 | |a KXP-PPN1759026352 |e 3931722007 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Anna-Lena Volckmar, Petros Christopoulos, Martina Kirchner, Michael Allgäuer, Olaf Neumann, Jan Budczies, Eugen Rempel, Peter Horak, Julia Glade, Hannah Goldschmid, Huriye Seker-Cin, Regine Brandt, Mark Kriegsmann, Jonas Leichsenring, Hauke Winter, Martin Faehling, Jürgen R. Fischer, Claus Peter Heußel, Felix Herth, Tilman Brummer, Stefan Fröhling, Peter Schirmacher, Michael Thomas, Volker Endris, Roland Penzel, Daniel Kazdal, Tilmann Bochtler, Albrecht Stenzinger"]},"id":{"eki":["1759026352"],"doi":["10.1016/j.lungcan.2021.02.022"]},"recId":"1759026352","physDesc":[{"extent":"11 S."}],"relHost":[{"pubHistory":["1.1985 -"],"origin":[{"dateIssuedKey":"1985","publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1985-","publisher":"Elsevier"}],"title":[{"subtitle":"journal of the International Association for the Study of Lung Cancer","title_sort":"Lung cancer","title":"Lung cancer"}],"part":{"year":"2021","pages":"131-141","extent":"11","volume":"154","text":"154(2021) vom: Apr., Seite 131-141"},"id":{"zdb":["2025812-4"],"issn":["1872-8332"],"eki":["320649733"]},"note":["Gesehen am 20.02.20"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320649733","physDesc":[{"extent":"Online-Ressource"}],"disp":"Targeting rare and non-canonical driver variants in NSCLC an uncharted clinical fieldLung cancer"}],"person":[{"family":"Volckmar","role":"aut","given":"Anna-Lena","display":"Volckmar, Anna-Lena"},{"family":"Christopoulos","role":"aut","given":"Petros","display":"Christopoulos, Petros"},{"family":"Kirchner","given":"Martina","role":"aut","display":"Kirchner, Martina"},{"given":"Michael","role":"aut","family":"Allgäuer","display":"Allgäuer, Michael"},{"given":"Olaf","role":"aut","family":"Neumann","display":"Neumann, Olaf"},{"family":"Budczies","given":"Jan","role":"aut","display":"Budczies, Jan"},{"display":"Rempel, Eugen","role":"aut","given":"Eugen","family":"Rempel"},{"given":"Peter","role":"aut","family":"Horak","display":"Horak, Peter"},{"given":"Julia","role":"aut","family":"Glade","display":"Glade, Julia"},{"family":"Goldschmid","given":"Hannah","role":"aut","display":"Goldschmid, Hannah"},{"family":"Şeker-Cin","role":"aut","given":"Huriye","display":"Şeker-Cin, Huriye"},{"display":"Brandt, Regine","role":"aut","given":"Regine","family":"Brandt"},{"role":"aut","given":"Mark","family":"Kriegsmann","display":"Kriegsmann, Mark"},{"display":"Leichsenring, Jonas","given":"Jonas","role":"aut","family":"Leichsenring"},{"given":"Hauke","role":"aut","family":"Winter","display":"Winter, Hauke"},{"display":"Faehling, Martin","given":"Martin","role":"aut","family":"Faehling"},{"role":"aut","given":"Jürgen","family":"Fischer","display":"Fischer, Jürgen"},{"display":"Heußel, Claus Peter","family":"Heußel","role":"aut","given":"Claus Peter"},{"display":"Herth, Felix","family":"Herth","given":"Felix","role":"aut"},{"display":"Brummer, Tilman","given":"Tilman","role":"aut","family":"Brummer"},{"display":"Fröhling, Stefan","given":"Stefan","role":"aut","family":"Fröhling"},{"display":"Schirmacher, Peter","given":"Peter","role":"aut","family":"Schirmacher"},{"display":"Thomas, Michael","family":"Thomas","given":"Michael","role":"aut"},{"given":"Volker","role":"aut","family":"Endris","display":"Endris, Volker"},{"display":"Penzel, Roland","given":"Roland","role":"aut","family":"Penzel"},{"family":"Kazdal","role":"aut","given":"Daniel","display":"Kazdal, Daniel"},{"family":"Bochtler","given":"Tilmann","role":"aut","display":"Bochtler, Tilmann"},{"display":"Stenzinger, Albrecht","family":"Stenzinger","given":"Albrecht","role":"aut"}],"origin":[{"dateIssuedDisp":"19 February 2021","dateIssuedKey":"2021"}],"title":[{"title_sort":"Targeting rare and non-canonical driver variants in NSCLC","title":"Targeting rare and non-canonical driver variants in NSCLC","subtitle":"an uncharted clinical field"}],"note":["Gesehen am 27.05.2021"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a VOLCKMARANTARGETINGR1920 | ||